PMID: 11605166Oct 18, 2001Paper

Principles and problems of transfusion in sickle cell disease

Seminars in Hematology
M J Telen

Abstract

Sickle cell disease (SCD) is associated with red blood cell (RBC) abnormalities and moderate to severe anemia, and blood transfusion is naturally a mainstay of treatment. However, transfusion therapy for SCD may incur special and distinctive adverse effects. Thus, it is important to understand the indications for and goals of transfusion therapy and to be aware of the potential side effects of therapy. Years of unsystematic clinical observations, followed by more carefully designed and in some cases randomized studies, have contributed substantially to our knowledge of transfusion therapy in SCD. However, much remains unknown and areas of controversy persist. In addition, serologic barriers pose enduring roadblocks to the optimization of transfusion therapy for patients with SCD, and the syndrome of massive hemolytic transfusion reactions and hyperhemolysis in SCD persists as a life-threatening complication for which appropriate clinical management is not yet defined.

Citations

Feb 27, 2009·Current Opinion in Pediatrics·Shannon Wahl, Keith C Quirolo
May 22, 2010·Advances in Hematology·Radha RaghupathyJane A Little
Jun 23, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Ilknur KozanogluMahmut Kural
Feb 27, 2004·British Journal of Haematology·Brenda E S GibsonG Turner
Oct 26, 2007·Transfusion·Araba Afenyi-AnnanRichard Lottenberg
Apr 19, 2005·Best Practice & Research. Clinical Gastroenterology·Shahid AhmedLinda A Russo
Jan 1, 2013·TheScientificWorldJournal·J MakaniK Ohene-Frempong
Nov 25, 2006·Hematology·Paul S Swerdlow
Dec 6, 2011·Veterinary Clinical Pathology·Cynthia de A LucidiMichael A Scott
Dec 6, 2011·Veterinary Clinical Pathology·Elif Ergul EkizUrs Giger
Apr 5, 2014·Journal of Veterinary Emergency and Critical Care·Raffaella CorsiKelly S Swanson
Jun 27, 2003·American Journal of Hematology·Shahid AhmedJoseph Mattana
Jun 4, 2008·Critical Pathways in Cardiology·Rajmony PannuPeter Mancusi-Ungaro
Sep 2, 2014·Advances in Hematology·Ademola Samson Adewoyin, Jude Chike Obieche
Apr 26, 2012·British Journal of Haematology·Ersi VoskaridouEvangelos Terpos
Jan 17, 2017·British Journal of Haematology·Bernard A DavisUNKNOWN British Committee for Standards in Haematology
Sep 6, 2018·Vox Sanguinis·Micah T ProchaskaDavid O Meltzer
Oct 14, 2016·Journal of Veterinary Internal Medicine·A MiglioF Passamonti
Feb 6, 2021·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Samuel J OfforOrish E Orisakwe
Mar 8, 2021·Journal of Thrombosis and Thrombolysis·Oluwabukola Temitope GbotoshoPunam Malik
Oct 11, 2005·Hematology/oncology Clinics of North America·Sam O Wanko, Marilyn J Telen
Mar 28, 2006·Transfusion Medicine Reviews·Lawrence D Petz

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis
Turiddu LombardoSalvatore Pennisi
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
N I OguanobiO G Ibegbulam
© 2021 Meta ULC. All rights reserved